{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:58:21Z","timestamp":1742803101553,"version":"3.37.3"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5 K12 HL 087165"],"award-info":[{"award-number":["5 K12 HL 087165"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AIDS Malignancy Consortium","award":["UM1 CA121947"],"award-info":[{"award-number":["UM1 CA121947"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191967","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T13:35:34Z","timestamp":1517492134000},"page":"e0191967","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-0376","authenticated-orcid":true,"given":"Manoj","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocent","family":"Mutyaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Okuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Harlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson","family":"Orem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Casper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"ref1","unstructured":"Ferlay J, Soeriomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/globocan.iarc.fr\" xlink:type=\"simple\">http:\/\/globocan.iarc.fr<\/ext-link>. Af. Cancer Incidence and Mortality Worldwide Lyon, France: International Agency for Research on Cancer.; 2013. IARC CancerBase No. 11 [Internet].:; GLOBOCAN 2012 v1.0,:[GLOBOCAN 2012 v1.0,]."},{"key":"ref2","article-title":"Global Cancer Facts and Figures","author":"M JA Garcia","year":"2007","journal-title":"American Cancer Society"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study","volume":"13","author":"F Bray","year":"2012","journal-title":"The lancet oncology"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QAI.0b013e31820c011a","article-title":"Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment","volume":"56","author":"MH Bateganya","year":"2011","journal-title":"Journal of acquired immune deficiency syndromes"},{"article-title":"J Clin Oncol","year":"2013","author":"IOJ Mutyaba","key":"ref5"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00520-006-0079-9","article-title":"Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review","volume":"14","author":"CA Hauser","year":"2006","journal-title":"Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1","article-title":"Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study","volume":"75","author":"M Maltoni","year":"1995","journal-title":"Cancer"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archinte.1988.00380070082020","article-title":"Clinical symptoms and length of survival in patients with terminal cancer","volume":"148","author":"DB Reuben","year":"1988","journal-title":"Archives of internal medicine"},{"key":"ref9","article-title":"Contribution of HIV infection to mortality among cancer patients in Uganda","author":"AE Coghill","year":"2013","journal-title":"Aids"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin&apos;s disease: Cotswolds meeting","volume":"7","author":"TA Lister","year":"1989","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Z Bursac","year":"2008","journal-title":"Source code for biology and medicine"},{"issue":"6","key":"ref12","first-page":"928","article-title":"Non-Hodgkin&apos;s lymphoma in patients 80 years of age or older. Annals of oncology: official journal of the European Society for Medical Oncology \/","volume":"17","author":"O Bairey","year":"2006","journal-title":"ESMO"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"B Coiffier","year":"2002","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0145-2126(01)00163-1","article-title":"Non-Hodgkin&apos;s lymphoma in patients 70 years of age or older: factors associated with survival","volume":"26","author":"J Cuttner","year":"2002","journal-title":"Leukemia research"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/annonc\/mdi264","article-title":"Chemotherapy dose intensity in non-Hodgkin&apos;s lymphoma: is dose intensity an emerging paradigm for better outcomes?","volume":"16","author":"SA Gregory","year":"2005","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood-2003-06-2095","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL","volume":"104","author":"M Pfreundschuh","year":"2004","journal-title":"Blood"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"MM Oken","year":"1982","journal-title":"American journal of clinical oncology"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","article-title":"Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution","volume":"32A","author":"G Buccheri","year":"1996","journal-title":"European journal of cancer"},{"issue":"Suppl 1","key":"ref19","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1038\/bjc.2015.48","article-title":"Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review","volume":"112","author":"RD Neal","year":"2015","journal-title":"British journal of cancer"},{"issue":"14","key":"ref20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A Predictive Model for Aggressive Non-Hodgkin&apos;s Lymphoma","volume":"329","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"P Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"ref22","article-title":"Chemotherapy Use, Performance Status, and Quality of Life at the End of Life","author":"HG Prigerson","year":"2015","journal-title":"JAMA oncology"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.1998.16.6.2065","article-title":"Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin&apos;s lymphoma: results of a multivariate analysis","volume":"16","author":"H Gomez","year":"1998","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"21","key":"ref24","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic Review","volume":"25","author":"NM Kuderer","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"MS Aapro","year":"2011","journal-title":"European journal of cancer"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"AG Freifeld","year":"2011","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref27","unstructured":"NCCN. National Comprehensive Cancer Network. Myeloid growth factors [updated v1020012; cited 2014]."},{"issue":"19","key":"ref28","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"TJ Smith","year":"2006","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Ethier M-C, Blanco E, Lehrnbecher T, Sung L. Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples2011 2011-11-10 00:00:00. 5080\u20133 p.","DOI":"10.1182\/blood-2011-07-363333"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1471-0528.2008.01866.x","article-title":"Maternal mortality in sub-Saharan Africa: the contribution of ineffective blood transfusion services","volume":"115","author":"I Bates","year":"2008","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jcp.2006.043505","article-title":"Transfusion in sub-Saharan Africa: does a Western model fit?","volume":"60","author":"SP Field","year":"2007","journal-title":"Journal of Clinical Pathology"},{"key":"ref32","first-page":"339","article-title":"Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory","volume":"4","author":"J Orem","year":"2012","journal-title":"Clinical epidemiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:34:12Z","timestamp":1570667652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191967"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191967","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}